| Indications/Age (Yrs) | <30 | 31-40 | 41-50 | 51-60 | 60+ | Total (%) |
|---|---|---|---|---|---|---|
| Retinal Vein Occlusion + CME | - | - | 2 | 7 | 17 | 26 (19.4) |
| Wet AMD | - | - | 2 | 4 | 17 | 23 (17.1) |
| Sickle cell Retinopathy + Vit. Heam. | 4 | 11 | 3 | 4 | - | 22 (16.4) |
| Prolif Diabetic Retinopathy +Vit Haem | - | - | 4 | 3 | 6 | 13 (9.7) |
| Diabetic Macular Edema | - | - | 2 | 2 | 6 | 10 (7.5) |
| Branch Retinal Vein Occlusion + Vit. Haem. | - | - | 2 | 1 | 7 | 10(7.5) |
| Idiopathic Polypoidal Choroidal Vasculopathy | - | - | 1 | 2 | 5 | 8(6.0) |
| Idiopathic CNVM | - | - | 6 | - | 1 | 7(5.2) |
| Neovascular Glaucoma | - | - | 2 | 3 | 2 | 7(5.2) |
| Retinal arterial macroaneurism | - | - | - | 4 | 2 | 6(4.5) |
| Others | 1 | - | - | 1 | - | 2(1.5) |
| Total | 5 | 11 | 24 | 31 | 63 | 134(100) |